The battle in the obesity drug market The battle in the obesity drug market was a key story in 2025 marked by bidding wars in mergers and acquisitions, restructuring and leadership changes at Novo Nordisk, and a race to have the first oral GLP-1 agonist for treating obesity
03 Mindfulness, without the woo
Research suggests there are several mechanisms by which semaglutide may influence biological aging
Outside of that specific ineligibility scenario, HumeCare's Terms state plainly that all other fees are non-refundable, and there are no prorated refunds for partially used membership periods - including annual plans canceled before the end of a paid term, where HumeCare states you retain access through the end of the term but receive no partial refund
Clinical studies have investigated ALA for oxidative stress, metabolic health, and diabetic neuropathy, making it one of the most versatile alternatives to NAC.65 66 67 Our guide to the best alpha-lipoic acid supplements takes a closer look at the evidence and our top recommendations
